Adverse effects of advanced glycation end products on embryonal development. 2008

Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or those who smoke, on embryonal development. Pronuclear (PN) embryos were obtained by flushing the fallopian tubes of rats after superovulation and mating. The cleavage rate and blastocyst yield were evaluated at 24, 72, 96, and 120 h of culture. Glyoxal, an AGE-forming aldehyde, suppressed embryonal development at every stage from PN to blastocyst in a concentration-dependent manner. The cleavage rate of the embryo was also signifi cantly decreased by treatment with glyoxal at concentrations of 1 mM or higher. The blastocyst yield was significantly decreased by treatment with glyoxal at concentrations of 0.5 mM or higher. N-acetyl-L-cysteine (L-NAC) at 1 mM significantly suppressed the glyoxal-induced embryonal toxicity. BSA-AGEs at 5 microg/ml or higher concentration signifi cantly reduced the cleavage rate and blastocyst yield compared to those for BSA-treated embryos. L-NAC at 1 mM significantly suppressed BSAAGE-induced embryonal toxicity. Because AGEs are embryo-toxic, AGE contamination may influence the pregnancy rate of in vitro fertilization and embryo transfer. AGEs, which are increased in women under pathological conditions, may also be involved in their infertility.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006037 Glyoxal A 2-carbon aldehyde with carbonyl groups on both carbons. Ethanedial,Ethanedione
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017127 Glycation End Products, Advanced A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in PROTEINS; LIPIDS; or NUCLEIC ACIDS. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking. Advanced Glycation End Product,Advanced Glycation Endproduct,Advanced Maillard Reaction End Product,Glycated Lipids,Glycotoxins,Maillard Product,Maillard Reaction End Product,Maillard Reaction Product,Advanced Glycation End Products,Advanced Glycation Endproducts,Advanced Maillard Reaction End Products,Glycation Endproducts, Advanced,Maillard Products,Maillard Reaction End Products,Maillard Reaction Products,Glycation Endproduct, Advanced,Lipids, Glycated,Product, Maillard Reaction,Products, Maillard,Products, Maillard Reaction,Reaction Products, Maillard
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
April 2021, Journal of biochemical and molecular toxicology,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
September 2021, Biochemical and biophysical research communications,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
January 2011, Contributions to nephrology,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
July 2017, The Journal of allergy and clinical immunology,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
January 2015, International journal of endocrinology,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
January 2014, Mediators of inflammation,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
April 2022, Oral diseases,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
January 2023, Nutrients,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
April 2003, The American journal of pathology,
Lin Hao, and Soichi Noguchi, and Yasuhiko Kamada, and Aiko Sasaki, and Miwa Matsuda, and Keiko Shimizu, and Yuji Hiramatsu, and Mikiya Nakatsuka
April 2024, Experimental dermatology,
Copied contents to your clipboard!